Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks.

Kosalaraksa P, Bunupuradah T, Engchanil C, Boonrak P, Intasan J, Lumbiganon P, Burger D, Ruxrungtham K, Schutz M, Ananworanich J; HIV-NAT 017 Study Team.

Pediatr Infect Dis J. 2008 Jul;27(7):623-8. doi: 10.1097/INF.0b013e31816b4539.

PMID:
18520443
2.

Lopinavir/ritonavir: a protease inhibitor for HIV-1 treatment.

Barragan P, Podzamczer D.

Expert Opin Pharmacother. 2008 Sep;9(13):2363-75. doi: 10.1517/14656566.9.13.2363 . Review.

PMID:
18710360
3.

Lopinavir/ritonavir (ABT-378/r).

Qazi NA, Morlese JF, Pozniak AL.

Expert Opin Pharmacother. 2002 Mar;3(3):315-27. Review.

PMID:
11866671
4.

Saquinavir/Ritonavir: its evolution and current treatment role.

O'Brien WA 3rd.

AIDS Read. 2006 Jan;16(1):38-44; discussion 43. Review.

PMID:
16433471
6.

HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review.

Bierman WF, van Agtmael MA, Nijhuis M, Danner SA, Boucher CA.

AIDS. 2009 Jan 28;23(3):279-91. doi: 10.1097/QAD.0b013e32831c54e5. Review.

PMID:
19114854
7.

Lopinavir/ritonavir in the treatment of human immunodeficiency virus infection.

Kaplan SS, Hicks CB.

Expert Opin Pharmacother. 2005 Aug;6(9):1573-85. Review.

PMID:
16086645
8.

Overview of boosted protease inhibitors in treatment-experienced HIV-infected patients.

Youle M.

J Antimicrob Chemother. 2007 Dec;60(6):1195-205. Epub 2007 Sep 21. Review.

PMID:
17890281
9.

Ritonavir-boosted protease inhibitor monotherapy for the treatment of HIV-1 infection.

Sahali S, Chaix ML, Delfraissy JF, Ghosn J.

AIDS Rev. 2008 Jan-Mar;10(1):4-14. Review.

PMID:
18385776
11.

Safety and antiviral activity of lopinavir/ritonavir-based therapy in human immunodeficiency virus type 1 (HIV-1) infection.

Kaplan SS, Hicks CB.

J Antimicrob Chemother. 2005 Aug;56(2):273-6. Epub 2005 Jun 30. Review.

PMID:
15994247
12.

Monotherapy with lopinavir/ritonavir.

Schechter M, Nunes EP.

Expert Opin Investig Drugs. 2007 May;16(5):735-41. Review.

PMID:
17461744
13.

Pharmacology and clinical experience with saquinavir.

Kravcik S.

Expert Opin Pharmacother. 2001 Feb;2(2):303-15. Review.

PMID:
11336588
14.

Broadening the perspective when assessing evidence on boosted protease inhibitor-based regimens for initial antiretroviral therapy.

Hornberger J, Simpson K, Shewade A, Dietz B, Baran R, Podsadecki T.

Adv Ther. 2010 Nov;27(11):763-73. doi: 10.1007/s12325-010-0075-9. Epub 2010 Oct 7. Review.

PMID:
20931365
15.

Saquinavir: a review of its use in boosted regimens for treating HIV infection.

Plosker GL, Scott LJ.

Drugs. 2003;63(12):1299-324. Review.

PMID:
12790697
16.

Saquinavir/low-dose ritonavir: its use in HIV infection.

Johnson M, Peters B.

AIDS Rev. 2003 Jan-Mar;5(1):44-51. Review.

PMID:
12875107
17.

Lopinavir/ritonavir: appraisal of its use in HIV therapy.

von Hentig N.

Drugs Today (Barc). 2007 Apr;43(4):221-47. Review.

PMID:
17460785
18.
19.

A review of low-dose ritonavir in protease inhibitor combination therapy.

Cooper CL, van Heeswijk RP, Gallicano K, Cameron DW.

Clin Infect Dis. 2003 Jun 15;36(12):1585-92. Epub 2003 Jun 5. Review.

PMID:
12802760
20.

Safety of lopinavir/ritonavir for the treatment of HIV-infection.

Vogel M, Rockstroh JK.

Expert Opin Drug Saf. 2005 May;4(3):403-20. Review.

PMID:
15934849

Supplemental Content

Support Center